---
title: "US FDA says J&J's Ethicon issues correction related to surgical stapler"
description: "The U.S. FDA announced that Ethicon, a Johnson & Johnson unit, issued a serious correction for certain lots of its surgical stapler component due to a malfunction that can lead to life-threatening sit"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/250181938.md"
published_at: "2025-07-25T15:39:39.000Z"
---

# US FDA says J&J's Ethicon issues correction related to surgical stapler

> The U.S. FDA announced that Ethicon, a Johnson & Johnson unit, issued a serious correction for certain lots of its surgical stapler component due to a malfunction that can lead to life-threatening situations. The device, used to cut and close tissue, may fail during surgery, resulting in one reported death and one injury. Ethicon has informed affected customers but has not initiated a full product recall. Healthcare facilities are advised to review the affected batches and ensure staff are familiar with the device's usage instructions.

July 25 (Reuters) - The U.S. drug regulator said on Friday Ethicon Endo-Surgery, a unit of Johnson & Johnson (JNJ.N) , issued a correction for certain lots of a part related to its surgical stapler and classified the action as “most serious”.

The issue is related to the device ‘Endopath Echelon Vascular White Reload for Advanced Placement Tip’ which tends to inadvertently lockout during surgical procedures, the Food and Drug Administration said on its website.

“There has been one reported death and one injury related to this issue,” the agency added.

The part in question is a single-use cartridge that surgeons load into a stapler to cut and close blood vessels or tissue during an operation. This helps control bleeding and close wounds quickly.

However, the FDA said the device may sometimes appear to work but fail to cut or staple tissue during surgery, and could lead to life-threatening bleeding, surgical delays, or death.

Ethicon notified its affected customers through a correction letter in April, but the company’s action is not a full product recall, the agency said.

The FDA said Ethicon has advised healthcare facilities to review affected batches and ensure operating room personnel are familiar with the device’s instructions for use and lockout mitigation protocols.

Johnson & Johnson did not immediately respond to a Reuters request for comment.

### Related Stocks

- [JNJ.US - Johnson & Johnson](https://longbridge.com/en/quote/JNJ.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years? | Johnson & Johnson (JNJ) is a leading healthcare company known for its 62 consecutive years of dividend increases. Despit | [Link](https://longbridge.com/en/news/259050773.md) |
| Wealth Advisory Team LLC Buys Shares of 1,548 Johnson & Johnson $JNJ | Wealth Advisory Team LLC acquired 1,548 shares of Johnson & Johnson (NYSE: JNJ) during Q2, valued at approximately $236, | [Link](https://longbridge.com/en/news/261200197.md) |
| ConocoPhillips considers selling Permian assets worth $2 billion, Bloomberg News reports | Feb 20 (Reuters) - ConocoPhillipsis exploring a sale of some of its Permian Basin assets as part of a broader streamlini | [Link](https://longbridge.com/en/news/276478732.md) |
| IronBridge Private Wealth LLC Has $905,000 Holdings in Apple Inc. $AAPL | IronBridge Private Wealth LLC reduced its stake in Apple Inc. (NASDAQ:AAPL) by 77.3% in Q3, holding 3,555 shares valued  | [Link](https://longbridge.com/en/news/276436345.md) |
| Financial Advocates Investment Management Lowers Stock Position in Meta Platforms, Inc. $META | Financial Advocates Investment Management reduced its stake in Meta Platforms, Inc. by 66.7% in Q3, now holding 2,343 sh | [Link](https://longbridge.com/en/news/276432394.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.